Kinarus Therapeutics Holding AGSWX Kinarus Therapeutics Stock Report

Kinarus Therapeutics Holding AG is a clinical stage biopharmaceutical company. The company is headquartered in Basel, Basel-Stadt. The firm conducts its work within clinical-stage area and its activities include discovery, examination and development of medicines that are intended for the treatment of viral, respiratory, and ophthalmic diseases. Kinraus therapeutic drug is patent protected KIN001 which is a combination of pamapimod and pioglitazone. KIN0001 offers oral, long-term treatment of diseases with severe impact on the comfort of living.